The polycystic ovary syndrome market is growing at an annualized rate of 4%, claims Roots Analysis

polycystic ovary syndrome affects 1 in 10 women of childbearing age. The exact cause of the condition is unknown; however, obesity, high levels of inflammation and insulin resistance are the common risk factors

Roots Analysis is pleased to announce the publication of its recent study, titled, “Polycystic Ovary Syndrome Market, 2021-2031.”

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
 A detailed assessment of the therapeutic pipeline activity and therapeutic assessment of the products.
 Detailed profiles of the players that are engaged in the development of drug products / therapies for polycystic ovarian syndrome.
 An insightful market assessment summary, highlighting the clinical and commercial attractiveness of pipeline molecules (phase II and phase III).
 A detailed analysis identifying the key opinion leaders (KOLs), featuring a 2X2 analysis to assess the relative experience of certain KOLs.
 An insightful analysis of the patents filed / granted for polycystic ovary syndrome, since 2016, taking into consideration various parameters.
 An in-depth analysis of grants awarded to various research institutes for the projects related to polycystic ovary syndrome, in the period between 2016 and April 2021.
 A detailed analysis of completed, ongoing and planned clinical studies, based on the various relevant parameters.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
 Drug Class
 Insulin Sensitizing Agents
 Oral Contraceptives
 Anti-Androgens
 Anti-Obesity
 Route of Administration
 Oral
 Subcutaneous
 Intravenous
 Others
 Regional Distribution
 North America (US, Canada)

Leave a Reply

Your email address will not be published. Required fields are marked *